| Literature DB >> 34837498 |
Ying-Xuan Xie1, Wen-Qi Lv1, Yi-Kun Chen1, Shunyan Hong1, Xiang-Ping Yao1, Wan-Jin Chen1, Miao Zhao2.
Abstract
Neurogenetic diseases are neurological conditions with a genetic cause (s). There are thousands of neurogenetic diseases, and most of them are incurable. The development of bioinformatics and elucidation of the mechanism of pathogenesis have allowed the development of gene therapy approaches, which show great potential in treating neurogenetic diseases. Viral vectors delivery, antisense oligonucleotides, gene editing, RNA interference, and burgeoning viroid delivery technique are promising gene therapy strategies, and commendable therapeutic effects in the treatment of neurogenetic diseases have been achieved (Fig. 1). This review highlights a sampling of advances in gene therapies for neurogenetic disorders. Fig. 1 Examples of gene therapy strategies used in the treatment of neurogenetic diseases. The schematic diagram shows different gene therapy approaches used for treating a sampling of neurogenetic disorders, such as ASO therapy, gene editing, gene augmentation, and RNA interference.Entities:
Keywords: Antisense oligonucleotides (ASOs); Gene editing; Gene therapy; Neurogenetic diseases
Mesh:
Substances:
Year: 2021 PMID: 34837498 DOI: 10.1007/s00109-021-02167-y
Source DB: PubMed Journal: J Mol Med (Berl) ISSN: 0946-2716 Impact factor: 4.599